Amylyx Pharmaceuticals to Participate in Upcoming November Investor Conferences
Business Wire•03/11/2026•09:00 ET
0
Key Highlights
- ➤Amylyx (AMLX) will hold fireside chats at two November healthcare conferences
- ➤Guggenheim conference presentation scheduled November 9, 2026, at 9:30 a.m. ET
- ➤Stifel conference presentation scheduled November 10, 2026, at 3:20 p.m. ET
- ➤Both presentations will be webcast live and replayable for 90 days
- ➤Amylyx is focused on four investigational therapies across endocrine and neurodegenerative diseases
Amylyx Pharmaceuticals to Participate in Upcoming November Investor Conferences
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will participate in the following upcoming investor conferences, which are being conducted in-person:
Get started
Create a free account to read the full story.